Chemomab Therapeutics Ltd. Operating Lease, Expense
Chemomab Therapeutics Ltd. (CMMB) reported Operating Lease, Expense of $242.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2021-03-09
- Chemomab Therapeutics Ltd. operating lease, expense for fiscal 2020 was $242.00K.
| Period end | Operating Lease, Expense 12 month |
|---|---|
| 2020-12-31 | $242.00K 10-K · filed 2021-03-09 |